FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.
Also called NCT05590871
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 180 participants
- Sponsor
- Shanghai Hongdian Medical CO., LTD
- Registry
-
NCT05590871
-
- Other papers using this trial's data
- Aorticorenal Ganglion Ablation Enhances Blood Pressure Reduction After Renal Denervation
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT05590871. Randomized; single masking; primary purpose treatment. Start 2023-03-31 (actual); primary completion 2025-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- FlashPoint Renal Denervation Under Columbus 3D Mapping System Guidance for Treating Hypertension
- Condition
- Hypertension
- Intervention (Device)
- FlashPoint renal denervation system
- Intervention (Other)
- Sham
- Lead sponsor
- Shanghai Hongdian Medical CO., LTD
Record details
- Record id
cardio:ct-nct05590871- Content hash
418eccc940b44f2768ac8bbca375b86bfbefbb26141383adbcf77c51a84bf893